ANTI-GANGLIOSIDE ANTIBODIES - ANVISA Registration 81148560037

Access comprehensive regulatory information for ANTI-GANGLIOSIDE ANTIBODIES in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81148560037 and manufactured by EUROIMMUN AG. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including BUHLMANN LABORATORIES AG, EUROIMMUN AG, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
2 Competitors
81148560037
Registration Details
ANVISA Registration Number: 81148560037
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

EUROLINE: Perfil gangliosídeos 2 (IgG)
Risk Class II

Registration Details

81148560037

25351943447201696

93741726000166

Company Information

EUROIMMUN AG
Germany
PT: ALEMANHA

Dates and Status

Nov 07, 2016

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "ANTI-GANGLIOSIDE ANTIBODIES"